Precipio enters distribution agreement with Fisher Healthcare for HemeScreen assays

Precipio, Inc.

Precipio (PRPO) entered a distribution agreement with Fisher Healthcare (Thermo Fisher Scientific) for HemeScreen assays.
Fisher Healthcare is one of the largest U.S. distributors of lab products, expanding Precipio's market reach.
Deal leverages existing sales channel instead of building a direct sales force, enhancing distribution and revenue potential.
Keith Meadors, Precipio SVP of Products, cited HemeScreen's accuracy, cost-effectiveness, and fast turnaround times.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.